Newsweek Selects Caristo Diagnostics as One of World's Best Digital Health Companies

Caristo Diagnostics United Kingdom England United States of America New Jersey

is a global leader in cardiac and vascular disease diagnostics and risk prediction. Founded in 2018 as a spin-out company from the University of Oxford, the world's #1 research university, Caristo has developed a portfolio of imaging-based and AI-assisted platforms that can be applied to aid the prediction and diagnosis of heart attack, stroke, and diabetes. Caristo has been recognized by Newsweek as one of the best digital health companies, and highlighted by Nature as one of the most exciting science-based companies to have emerged from academic labs. Find Caristo online on its website, LinkedIn and X.

Caristo Diagnostics contact:

Frank Cheng,
CEO
[e-mail]

Logo: https://mma.prnewswire.com/media/2054669/4675723/Caristo_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/newsweek-selects-caristo-diagnostics-as-one-of-worlds-best-digital-health-companies-302129840.html